tiprankstipranks
Milestone Pharmaceuticals (MIST)
:MIST
US Market

Milestone Pharmaceuticals (MIST) Income Statement

Compare
517 Followers

Milestone Pharmaceuticals Income Statement

Last quarter (Q3 2024), Milestone Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Milestone Pharmaceuticals's net income was $-9.44M. See Milestone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.00M$ 5.00M$ 15.00M$ 0.00$ 0.00
Gross Profit
$ 1.00M$ 4.52M$ 15.00M$ -376.00K$ -236.00K
Operating Expenses
$ 62.10M$ 64.64M$ 58.07M$ 50.71M$ 57.88M
Depreciation and Amortization
$ 92.00K$ 480.00K$ 362.00K$ 376.00K$ 236.00K
EBITDA
$ -56.84M$ -58.36M$ -42.98M$ -50.71M$ -57.88M
Operating Income
$ -61.10M$ -59.64M$ -43.07M$ -50.71M$ -57.88M
Other Income/Expenses
$ 1.41M$ 1.25M$ 220.00K$ 726.00K$ 2.60M
Pretax Income
$ -59.69M$ -58.39M$ -42.85M$ -49.98M$ -55.28M
Net Income
$ -59.69M$ -57.13M$ -42.63M$ -49.97M$ -55.23M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.39$ -1.35$ -1.02$ -1.70$ -3.50
Diluted EPS
$ -1.39$ -1.35$ -1.02$ -1.70$ -3.50
Weighted Average Shares Outstanding
42.96M 42.45M 41.83M 29.34M 15.78M
Weighted Average Shares Outstanding (Diluted)
42.96M 42.45M 41.83M 29.34M 15.78M
Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis